Related Experiment Video
Updated: Dec 27, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda1,2, Siu Semar Saratu' Langden1,2, Choijamts Munkhzul1,2
1Soonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan 31151, Korea.
Abstract:
Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3' UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs.
Insights
MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer. This review details how miRNA dysregulation, through genetic and epigenetic changes, drives cancer pathogenesis and progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Altered gene expression drives human diseases, notably cancer.
- MicroRNAs (miRNAs) regulate gene expression post-transcriptionally, impacting oncogenes and tumor suppressors.
- miRNA dysfunction is linked to cancer pathogenesis, with many miRNAs acting as oncomiRs or oncosuppressor miRs.
Purpose of the Study:
- To elucidate the molecular mechanisms of miRNA expression deregulation in cancer.
- To highlight the roles of transcriptional and post-transcriptional factors in miRNA dysregulation.
- To underscore the importance of understanding miRNA regulation for cancer research.
Main Methods:
- Review of existing literature on miRNA regulation in cancer.
- Analysis of genetic and epigenetic mechanisms affecting miRNA expression.
- Examination of transcription factor and processing pathway involvement.
Main Results:
- miRNA expression is altered in cancer via genetic deletion/amplification and epigenetic methylation.
- Transcription factors and miRNA biogenesis processing steps significantly impact miRNA levels in cancer.
- Dysregulated miRNAs contribute to cancer development by affecting oncogenic and tumor-suppressive genes.
Conclusions:
- Understanding miRNA deregulation mechanisms is crucial for comprehending cancer physiology.
- Transcriptional and post-transcriptional factors are key players in cancer-associated miRNA programs.
- Further research into miRNA regulation offers potential for novel cancer diagnostics and therapeutics.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression at Multiple Steps
Experimental RNAi
Epigenetic Regulation

